I D Hay

Author PubWeight™ 89.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery 2001 2.50
2 Thyroiditis: a clinical update. Mayo Clin Proc 1985 2.31
3 Distant metastases in differentiated thyroid carcinoma: a multivariate analysis of prognostic variables. J Clin Endocrinol Metab 1988 2.20
4 AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract 2001 2.15
5 Locally invasive papillary thyroid carcinoma: 1940-1990. Head Neck 1994 1.89
6 Thyroid carcinoma metastatic to the skin: a cutaneous manifestation of a widely disseminated malignancy. J Am Acad Dermatol 1997 1.85
7 Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 1986 1.84
8 Thyroid cancer nodal metastases: biologic significance and therapeutic considerations. Surg Oncol Clin N Am 1996 1.75
9 Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab 1995 1.71
10 Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis. Surgery 2000 1.63
11 Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest 1992 1.52
12 Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B. Surgery 1994 1.41
13 Letter: Thyrotoxic periodic paralysis in Britain. Br Med J 1975 1.38
14 Prognostic significance of calcitonin immunoreactivity, amyloid staining, and flow cytometric DNA measurements in medullary thyroid carcinoma. Surgery 1991 1.38
15 Follicular thyroid cancer. Endocrinol Metab Clin North Am 1995 1.31
16 Long-term course of patients with persistent hypercalcitoninemia after apparent curative primary surgery for medullary thyroid carcinoma. Ann Surg 1990 1.29
17 Thyroglossal duct carcinoma: report of 12 cases. Mayo Clin Proc 1997 1.27
18 Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery 1988 1.20
19 Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery 1988 1.17
20 Assessment of sensitive thyrotropin assays for an expanded role in thyroid function testing: proposed criteria for analytic performance and clinical utility. J Clin Endocrinol Metab 1987 1.15
21 Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers. J Clin Invest 1991 1.13
22 Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas. J Clin Invest 1991 1.11
23 Prognostic indicators in differentiated thyroid carcinoma. Cancer Control 2000 1.10
24 Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery 1992 1.10
25 Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma. Cancer 1990 1.09
26 Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma. AJR Am J Roentgenol 2002 1.08
27 Immunohistochemical analysis of sodium iodide symporter expression in metastatic differentiated thyroid cancer: correlation with radioiodine uptake. J Clin Endocrinol Metab 2001 1.07
28 Radioiodine-induced hypothyroidism in Graves' disease: factors associated. J Nucl Med 1982 1.05
29 Biochemical testing of thyroid function. Endocrinol Metab Clin North Am 1997 1.03
30 Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma. J Clin Endocrinol Metab 1997 1.01
31 Familial cytomegalic adrenocortical hypoplasia: an X-linked syndrome of pubertal failure. Arch Dis Child 1981 1.00
32 Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer? Thyroid 2000 1.00
33 Flow cytometric DNA measurements in benign and malignant Hürthle cell tumors of the thyroid. World J Surg 1988 0.97
34 Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods. Mayo Clin Proc 1988 0.97
35 The effect of the treatment of hypothyroidism and hyperthyroidism on plasma lipids and apolipoproteins AI, AII and E. Clin Endocrinol (Oxf) 1997 0.96
36 Medullary thyroid carcinoma: clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970. Mayo Clin Proc 1992 0.96
37 The use of radioactive iodine in patients with papillary and follicular thyroid cancer. J Clin Endocrinol Metab 1998 0.96
38 Long-term follow-up of patients with benign thyroid fine-needle aspiration cytologic diagnoses. Surgery 1989 0.94
39 Benign Hürthle cell tumors of the thyroid: a diagnosis to be trusted? World J Surg 1988 0.94
40 Mortality from papillary thyroid carcinoma. A case-control study of 56 lethal cases. Cancer 1988 0.92
41 Role of thyrotropin measurements in the diagnosis and management of thyroid disease. Clin Lab Med 1993 0.91
42 Non-Hodgkin's lymphoma of the thyroid: is more than biopsy necessary? World J Surg 1992 0.89
43 Hürthle cell (oxyphilic) papillary thyroid carcinoma: a variant with more aggressive biologic behavior. World J Surg 1992 0.89
44 Medullary thyroid carcinoma: role of high-resolution US. Radiology 1987 0.88
45 Treating the patient with differentiated thyroid cancer with thyroglobulin-positive iodine-131 diagnostic scan-negative metastases: including comments on the role of serum thyroglobulin monitoring in tumor surveillance. Semin Nucl Med 2000 0.88
46 US-guided biopsy of neck masses in postoperative management of patients with thyroid cancer. Radiology 1988 0.88
47 L-thyroxine contamination of pharmaceutical D-thyroxine: probable cause of therapeutic effect. Clin Pharmacol Ther 1984 0.87
48 Familial splenomegaly: macrophage hypercatabolism of lipoproteins associated with apolipoprotein E mutation [apolipoprotein E (delta149 Leu)]. J Clin Endocrinol Metab 2000 0.86
49 Follicular cell-derived thyroid carcinomas. Cancer Treat Res 1997 0.85
50 Follicular and Hürthle cell thyroid neoplasms. Is frozen-section evaluation worthwhile? Arch Surg 1997 0.85
51 Evidence for autoimmune mechanisms in the evolution of invasive fibrous thyroiditis (Riedel's struma). Clin Investig 1994 0.85
52 Heterophilic serum antibodies: a cause for falsely elevated serum thyrotropin levels. Mayo Clin Proc 1987 0.84
53 The association between Alzheimer's disease and thyroid disease in Rochester, Minnesota. Neurology 1991 0.84
54 Oncocytic tumours of the salivary gland, kidney, and thyroid: nuclear DNA patterns studied by flow cytometry. Br J Cancer 1986 0.84
55 Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors. Oncogene 1998 0.84
56 Pubertal failure in congenital adrenocortical hypoplasia. Lancet 1977 0.83
57 Pediatric endocrine surgery: a 20-year experience at the Mayo Clinic. J Clin Endocrinol Metab 2013 0.83
58 Contrasting effects of subcutaneous pulsatile GnRH therapy in congenital adrenal hypoplasia and Kallmann's syndrome. Clin Endocrinol (Oxf) 1984 0.82
59 Paraneoplastic cholestasis and hypercoagulability associated with medullary thyroid carcinoma. Resolution with tumor debulking. Cancer 1994 0.82
60 Tissue eosinophilia and eosinophil degranulation in Riedel's invasive fibrous thyroiditis. J Clin Endocrinol Metab 1996 0.81
61 Diagnostic and prognostic utility of flow cytometric DNA measurements in follicular thyroid tumors. World J Surg 1990 0.81
62 FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance. Clin Endocrinol (Oxf) 2000 0.81
63 A multidisciplinary study of the 'yips' phenomenon in golf: An exploratory analysis. Sports Med 2000 0.81
64 The effects of transforming growth factor-beta on growth and differentiation of the continuous rat thyroid follicular cell line, FRTL-5. Endocrinology 1988 0.81
65 Biochemical thyroid function testing. Mayo Clin Proc 1994 0.80
66 Familial resistance to thyroid hormone associated with decreased transport across the plasma membrane. Ann Intern Med 1983 0.80
67 The role of surgery in the management of differentiated thyroid cancer. J Endocrinol Invest 1997 0.80
68 Prognostic factors and management in thyroid cancer--consensus or controversy? West J Med 1996 0.79
69 Expression of a potential metastasis suppressor gene (nm23) in thyroid neoplasms. World J Surg 1994 0.79
70 Simultaneous determination of D- and L-thyroxine in human serum by liquid chromatography with electrochemical detection. J Chromatogr 1981 0.79
71 Revised nomenclature for tests of thyroid hormones and thyroid-related proteins in serum. J Clin Endocrinol Metab 1987 0.79
72 Revised nomenclature for tests of thyroid hormones and thyroid-related proteins in serum. Arch Pathol Lab Med 1987 0.79
73 Columnar cell carcinoma of the thyroid: report of three additional cases. Hum Pathol 1996 0.79
74 Further evidence for autoimmune mechanisms in the pathogenesis of Riedel's invasive fibrous thyroiditis. J Intern Med 1995 0.78
75 Persistent primary hyperparathyroidism: successful ultrasound-guided percutaneous ethanol ablation of an occult adenoma. Mayo Clin Proc 1988 0.78
76 Cryosurgery or microsurgery in the management of acromegaly. JAMA 1982 0.78
77 The effects of synthetic alpha-subunit peptides on thyroid-stimulating immunoglobulin activity. J Clin Endocrinol Metab 1988 0.77
78 Indications, technique, and efficacy of alcohol injection of enlarged parathyroid glands in patients with primary hyperparathyroidism. Surgery 1998 0.77
79 Insular thyroid carcinoma in adolescents: a potentially lethal endocrine malignancy. Cancer 1997 0.77
80 Semi-quantitative interpretation of the bone scan in metabolic bone disease: definition and validation of the metabolic index. Eur J Nucl Med 1979 0.77
81 Sensitive thyrotropin assays: analytic and clinical performance criteria. Mayo Clin Proc 1988 0.76
82 Brain metastases from papillary thyroid carcinoma. Arch Intern Med 1987 0.76
83 Assay for thyroid stimulating immunoglobulin. Mayo Clin Proc 1986 0.76
84 Serum immunoreactive melatonin in boys with delayed puberty. Clin Endocrinol (Oxf) 1982 0.76
85 A descriptive experience of total thyroidectomy as the initial operation for differentiated carcinoma of the thyroid. Am J Surg 1991 0.75
86 Thyrotoxic periodic paralysis. J R Soc Med 1980 0.75
87 Serum thyroglobulin in differentiated thyroid cancer. Br Med J 1979 0.75
88 Practical management of hyperthyroidism. Am Fam Physician 1990 0.75
89 Metoclopramide induced growth hormone release in hypogonadal males. Clin Endocrinol (Oxf) 1979 0.75
90 Stereospecific determination and in vivo monodeiodination of thyroxine enantiomers in euthyroid man. Metabolism 1985 0.75
91 Adrenal scintigraphy: comparison of the Anger tomoigraphic scanner and the large-field gamma camera: concise communication. J Nucl Med 1980 0.75
92 Failure of adrenal androgen to induce puberty in familial cytomegalic adrenocortical hypoplasia. Lancet 1982 0.75
93 [Papillary thyroid carcinoma: clinical manifestations, recurrences and prognosis]. Vestn Khir Im I I Grek 2006 0.75
94 Semi-quantitative analysis of the bone scan in acromegaly: correlation with human growth hormone values. Br J Radiol 1980 0.75
95 Controversies in nuclear medicine. Solitary thyroid nodule: fine needle aspiration, the first investigation. Nucl Med Commun 1989 0.75
96 Trans-sphenoidal surgery for acromegaly: a comparison of cryosurgery and microsurgery [proceedings]. J Endocrinol 1978 0.75
97 Euthyroid hyperthyroxinemia. Mayo Clin Proc 1985 0.75
98 Metoclopramide stimulation: a test of growth hormone reserve in adolescent males. Clin Endocrinol (Oxf) 1979 0.75
99 Cytogenetics of six follicular thyroid adenomas including a case report of an oxyphil variant with t(8;14)(q13;q24.1). Cancer Genet Cytogenet 1991 0.75
100 Nodal metastases from papillary thyroid carcinoma. Lancet 1986 0.75
101 High-resolution real-time ultrasonography and unsuspected micronodular thyroid disease. Lancet 1984 0.75
102 Growth hormone response to metoclopramide [proceedings]. J Endocrinol 1979 0.75
103 Effects of growth hormone, glucose and insulin on the factor VIII complex. Thromb Res 1982 0.75
104 Computer assistance: an essential for adrenal imaging. Br J Radiol 1979 0.75
105 Hypoglycemia during adrenergic beta-blockade: evidence against mediation via a deficiency of lactate for gluconeogenesis. Metabolism 1985 0.75
106 Extracervical fibrosclerosis causing obstruction of a ventriculo-peritoneal shunt in a patient with hydrocephalus and invasive fibrous thyroiditis (Riedel's struma). Clin Endocrinol (Oxf) 1997 0.75
107 Thyroid function, iodine nutrition and fetal brain development. Clin Endocrinol (Oxf) 1979 0.75